Abortion Pills are Safe and Evidence-Based
Medication abortion has been studied for decades, used by millions of people worldwide, and endorsed by leading medical authorities. Despite decades of rigorous medical evidence confirming that abortion medication is safe and effective, misinformation continues to distort public understanding and threatens access to this essential form of health care. As efforts to restrict access intensify, it is more important than ever that people understand the facts about abortion pills and the science behind them.
Below are key facts everyone should know.
How Abortion Pills Work
The most common medication abortion regimen uses two drugs in sequence. First, the pregnant person takes mifepristone, a synthetic antiprogestogen pill that blocks progesterone, the hormone needed for a pregnancy to continue. Mifepristone also softens the cervix and prepares the uterus to respond to the second drug.
Within 24-28 hours, the person takes misoprostol, which causes the uterus to contract and expel the pregnancy.
Both medications have multiple uses beyond abortion care. In some cases, mifepristone can be used to manage uterine fibroids, endometriosis, and induce labor. Misoprostol can be used to induce labor, as well as to treat postpartum hemorrhage.
What the Science Actually Says About Medication Abortion
The medical evidence supporting mifepristone and misoprostol is extensive and well established. These medications have been studied in thousands of clinical trials, monitored by the FDA for more than two decades, and endorsed by major medical organizations in the United States and worldwide. Mifepristone has one of the longest FDA post-market surveillance records of any reproductive health drug.
Together, this two-drug combination works in 87-98% of cases when used up to 14 weeks of pregnancy. Misoprostol can also be used alone to end a pregnancy, and is 85-95% effective up to 12 weeks. If the initial regimen does not fully end the pregnancy, taking an additional dose of misoprostol is typically a safe option to help end the pregnancy.
Since the FDA approved mifepristone in 2000, post-market surveillance has included over 5.6 million patients in the United States, and safety monitoring has shown that serious complications are extremely rare. For example, a large study published in Womens Health Issues analyzed 34,764 medication abortions and found serious complications in fewer than 0.3% of cases.
Global Scientific Consensus
Medication abortion is supported by a broad international medical consensus. Both mifepristone and misoprostol appear on the World Health Organisation's Model List of Essential Medicines, the international benchmark for drugs considered safe, effective, and fundamental to health systems globally. This is a designation earned through scientific evidence, not political considerations.
In the United States, major medical organizations are equally clear:
- American College of Obstetricians and Gynecologists (ACOG) affirms medication abortion as a safe, effective, and evidence-based component of reproductive health care.
- American Medical Association (AMA) has formally opposed restrictions on mifepristone that are not grounded in clinical evidence, citing the drug's established safety profile.
- The National Academies of Sciences, Engineering, and Medicine concluded in a comprehensive review that medication abortion is safe and effective, with complication rates below 1%.
- The Society of Family Planning has published extensive peer-reviewed literature supporting both the clinical evidence and the current regulatory framework surrounding medication abortion.
Taken together, these findings reflect a clear scientific consensus: medication abortion is a safe, effective, and essential part of modern health care.
Telehealth and Mail Dispensing: The Evidence
In January 2023, the FDA updated the mifepristone Risk Evaluation and Mitigation Strategy (REMS) to permit certified pharmacies to dispense the medication by mail. This decision followed an extensive review of research comparing telehealth and in-person provision.
A 2021 study published in Obstetrics & Gynecology compared outcomes between telehealth and in-person medication abortion, and researchers found no significant difference in safety outcomes. Based on the evidence, the FDA concluded that mandatory in-person dispensing was not necessary to ensure patient safety.
Why Access Matters
Access to abortion pills is essential to ensuring that people can decide if and when to continue a pregnancy. Yet political attacks on medication abortion—and the spread of misinformation by crisis pregnancy centers and other sources—continue to create confusion and barriers for people trying to find accurate information and timely care.
Reliable sources such as AbortionFinder help people navigate these challenges by providing up-to-date information on abortion laws, providers, and resources so that abortion seekers can find safe and reliable care.
Ensuring people can continue to find accurate information and access to medication abortion is critical to protecting people’s health, autonomy, and ability to make informed decisions about their own bodies.
